• Explored PK/PD properties of novel antibacterial agents, helping to optimize combination therapies used for infections due to multidrug resistant organisms• Led an 8-person research team of pharmacy students, residents and fellows that produced two peer reviewed publications and over ten poster presentations at various scientific meetings • Assisted with various aspects of a Phase I clinical trial (NCT02570074), including data collection and management, adverse drug event reporting, and evaluation of ex vivo pharmacodynamics• Developed research protocols for five projects ranging from compatibility assessment of IV administered antimicrobials to in vivo pharmacodynamics survival model analysis

• Worked with various departments to coordinate institutional regulatory approvals necessary to establish new research group, including development of all standard operating procedures• Researched adipose tissue association with pancreatic cancer proliferation, ultimately publishing as lead author in a peer reviewed journal• Managed finances of multiple NIH research grants totaling $1.6 million dollars • Trained and managed 10-person research team that produced four peer reviewed publications

• Explored adipose tissue inflammation and adipocyte metabolic dysregulation in the context of both diabetes and chronic obesity• Developed novel protocols to extract and manipulate human adipose tissue derived stem cells• Trained all new employees in scientific and technical aspects of the research group, assuming role oflead researcher for the group

• Analyzed various food and nutritional supplements for consistency and safety• Ensured a high level of quality testing, applying Good Manufacturing Practices and Good Laboratory Practices in an ISO accredited lab